Provided by Tiger Trade Technology Pte. Ltd.

Nektar Therapeutics

73.04
+0.82001.14%
Volume:57.46K
Turnover:4.20M
Market Cap:2.10B
PE:-7.51
High:73.96
Open:73.00
Low:72.60
Close:72.22
52wk High:77.00
52wk Low:6.48
Shares:28.69M
Float Shares:26.24M
Volume Ratio:3.19
T/O Rate:0.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.7300
EPS(LYR):-8.6765
ROE:-217.94%
ROA:-27.98%
PB:23.33
PE(LYR):-8.42

Loading ...

May 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2025

Major Issues Report

Form 8-K - Current report
Apr 04, 2025

Major Issues Report

Form 8-K - Current report
Mar 29, 2025

Correspondence

Form CORRESP - Correspondence
Mar 28, 2025

Major Issues Report

Form 8-K - Current report
Mar 14, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 14, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2025

Major Issues Report

Form 8-K - Current report
Feb 24, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 04, 2025

Major Issues Report

Form 8-K - Current report
Dec 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 02, 2024

Major Issues Report

Form 8-K - Current report